Oil prices rose to a new settlement high above US$56 a barrel on Friday, reflecting traders' fears about tight supply amid strong global demand.
OPEC tried to calm the markets this week but failed due to concerns about the oil cartel's limited ability to quickly add more barrels to the market.
Light, sweet crude for April delivery settled US$0.32 higher at US$56.72 a barrel on the New York Mercantile Exchange, topping the previous closing high of US$56.46 set on Wednesday. Crude futures set an intraday high of US$57.60 per barrel on Thursday.
"It still looks like we haven't found a top yet," said Tom Bentz, a broker at BNP Paribas Commodity Futures in New York.
Oil is 50 percent more expensive than a year ago but still well below the inflation-adjusted peak above US$90 a barrel set in 1980.
In London, Brent crude rose US$0.53 to US$55.59 a barrel on the International Petroleum Exchange.
The feverish rally in recent weeks -- prices up US$15 since the start of the year -- has been underpinned by a weak dollar and rising global demand at a time when there is very little excess supply immediately available. There are no fuel shortages, though traders are clearly pricing in that possibility, whether due to a terrorist attack, a refinery snag or some other unexpected supply bottleneck.
Although the Organization of Petroleum Exporting Countries (OPEC) agreed on Wednesday to boost its output quota by 500,000 barrels a day, or 1.9 percent, the market brushed off the decision. Since members are already producing above their quotas, no extra supply will actually be added, analysts said.
But OPEC left open the possibility of raising its output quota by an additional 500,000 barrels and signaled on Thursday that such a move could come as early as next week.
Because crude is denominated worldwide in US dollars, and because the currency has lost nearly 10 percent of its value against the euro in the past year, OPEC nations have signaled support for higher oil prices in order to maintain their buying power in Europe.
Lorraine Tan, Singapore director of research at Standard & Poor's Investment Services, said the market is also fueled by supply fundamentals, such as the insufficient investments in refineries.
"Many refineries are subject to shutdowns now because they are running on full capacity. So the market gets jittery," she said.
Just a few years ago, the millennial generation — generally defined as those born from the early 1980s through the mid-1990s — was synonymous with youthful rebellion. However, now, as the millennials ease into early middle age, they are finding their path out of their parents’ basement to be a lot harder than it was for earlier generations. The fundamental problem is that millennials are not building wealth. The wealth of the median US household headed by someone 35 or younger has actually shrunk in inflation-adjusted terms since the mid-2000s, even as the wealth of older Americans has continued to grow. An
Apple Inc’s decision to stop using Intel Corp processors in its Mac computers and switching to its own chips might benefit Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) and boost Taiwan’s high-tech exports, Australia and New Zealand Banking Group (ANZ) said in a note on Tuesday. The US tech giant announced the “Apple silicon” initiative at its annual Worldwide Developers’ Conference, which started on Monday. The company said the first Mac powered by its own chips would debut by the end of this year and all product lines might shift to the new architecture in the next two years. TSMC is likely to
Gogoro Inc (睿能創意) yesterday launched its first electric bicycle, the Gogoro Eeyo 1, in Taiwan, after unveiling the bike in New York in late May and in France on Tuesday. The company said it would also introduce the series in other European countries such as Germany and the Netherlands. The “Eeyo project” is the fourth of Gogoro’s eight projects that concentrate on smart transportation, which includes Gogoro’s electric scooter, battery swap system and electric scooter sharing service, company founder and chief executive officer Horace Luke (陸學森) told a media briefing in Taipei. “There are various types of city commuters. We will not
EXPERIMENTAL DRUG: While news about a COVID-19 vaccine is more eye-catching, developing a treatment would be more viable, the Senhwa boss said Senhwa Biosciences Inc (生華科) aims to raise NT$1.5 billion (US$50.57 million) by issuing 15 million new common shares in the third quarter of this year to fund the research of new drugs, including the experimental drug Silmitasertib for the treatment of COVID-19, the company said on Monday. That would be the firm’s largest fundraising effort after it raised more than NT$1.4 billion from an initial public offering on the Taipei Exchange (TPEX) in April 2017, chief financial officer Sarah Chang (張小萍) told the Taipei Times by telephone. The price of the new shares would depend on the firm’s average share price